Skip to main content
SpringerLink
Log in
Book cover

Growth Hormone And The Heart pp 195–206Cite as

Growth Hormone-Releasing Peptides And The Heart

  • Chapter

  • 97 Accesses

Part of the book series: Endocrine Updates ((ENDO,volume 9))

Abstract

In the past few years, search of compounds alternative to either GH or GHRH, endowed with oral bioavailability and high effectiveness, has resulted in the development of a new family of molecules named growth hormone-releasing peptides (GHRPs). This family now comprises a number of different short peptidyl and non-peptidyl agonists, some of which have been already proven to be effective in humans, and for this reason these compounds are more generally referred to as the growth hormone secretagogues (GHSs). At present, no cardiac effects of the non-peptidyl compounds have been reported and therefore in this chapter we will focus on the cardiovascular actions of GHRPs.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982;218:585–587.

    Article  PubMed  CAS  Google Scholar 

  2. Rivier J, Spiess J, Thorner MO, Vale WW. Characterization of a growth hormone-releasing factor from a human pancreatic islet cell tumour. Nature 1982;300:276–278.

    Article  PubMed  CAS  Google Scholar 

  3. Bowers CY, Chang J, Momany F, Folkers K. Effect of the enkephalins and enkephalin analogs on release of pituitary hormones, in vitro. In: Maclntyre G, Szelke H eds. Molecular Endocrinology. Amsterdam: Elsevier/North Holland 1977:287–92.

    Google Scholar 

  4. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1980;106:663–667.

    Article  PubMed  CAS  Google Scholar 

  5. Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 1984;114:1531–1536.

    Article  PubMed  CAS  Google Scholar 

  6. Bowers CY, Momany FA, Reynolds GA, Hong A: On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537–1545.

    Article  PubMed  CAS  Google Scholar 

  7. Croom WJ, Leonard ES, Baker PK, Kraft LA, Ricks CA. The effects of synthetic growth hormone releasing hexapeptide BI 679 on serum growth hormone levels and production in lactating dairy cattle. J Anim Sci 1984;67–109.

    Article  Google Scholar 

  8. Kraft LA, Baker PK, Doscher ME, Ricks CA. Effect of a synthetic growth hormone releasing hexapeptide on serum growth hormone levels in steers. J Anim Sci 1984;59–218.

    Google Scholar 

  9. Doscher ME, Baker PK, Kraft LA, Ricks CA. Effect of a synthetic growth hormone releasing hexapeptide (BI 679) and growth hormone releasing factor (GRF) on serum growth hormone levels in barrows. J Anim Sci 1984;59:218.

    Google Scholar 

  10. Malozowski S, Hao EN, Ren SG, et al. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomologus macaque: evidence for non-GHRH-mediated responses. J Clin Endocrinol Metab 1991;73:314–317.

    Article  PubMed  CAS  Google Scholar 

  11. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 1989;69:212–4.

    Article  PubMed  CAS  Google Scholar 

  12. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thonier MO. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990;70:975–982.

    Article  PubMed  CAS  Google Scholar 

  13. Walker RF, Codd EE, Barone FC, Nelson AH, Goodwin T, Campbell SA. Oral activity of the growth hormone releasing peptide His-DTrp-Ala-Trp-DPhe-Lys-NH2 in rat, dogs, monkeys. Life Sci 1990;47:29–36.

    Article  PubMed  CAS  Google Scholar 

  14. Bowers CY, Alster DK, Frentz JM. The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 1992; 74:292–298.

    Article  PubMed  CAS  Google Scholar 

  15. Cella SG, Cerri CG, Daniel S, et al. Sixteen weeks of Hexarelin therapy in aged dogs: effecs on the somatotropic axis, muscle morphology, and bone metabolism. J Gerontol 1996;51A:B439–B447.

    Article  CAS  Google Scholar 

  16. Arvat E, Di Vito L, Lanfranco F, et al. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. J Endocrinol Invest 1999;22:91–97.

    PubMed  CAS  Google Scholar 

  17. Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE, Locatelli V. GH-releasing activity of Hexarelin, a new growth hormone-releasing peptide, in infant and adult rats. Life Sci 1994;54:1321–1328.

    Article  PubMed  CAS  Google Scholar 

  18. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;39:552–561.

    Article  Google Scholar 

  19. Akman MS, Girard M, O’Brien LF, Ho AK, Chik CL. Mechanisms of action of asecond generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys­NH2) in rat anterior pituitary cells Endocrinology 1993;132:1286–1291.

    Article  PubMed  CAS  Google Scholar 

  20. McCormick GF, Millard WJ, Badger TM, Bowers CY, Martin JB. Dose-response characteristics of various peptides with growth hormone-releasing activity in the unanesthetized male rat. Endocrinology 1985;117:97–105.

    Article  PubMed  CAS  Google Scholar 

  21. Elias KA, Ingle GS, Burnier JP, et al. In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 1995;136:5694–5699.

    Article  PubMed  CAS  Google Scholar 

  22. Deghenghi R, Boutignon F, Luoni M, Grilli R, Guidi M, Locatelli V. Small peptides as potent releasers of growth hormone. J Ped Endocrin Met 1995;8:311–313.

    CAS  Google Scholar 

  23. McDowell RS, Elias KA, Stanley MS, et al. Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA 1995;92:11165–11169.

    Article  PubMed  CAS  Google Scholar 

  24. Smith RG, Cheng K, Schoen WR, et al. A nonpeptidyl growth hormone secretagogue. Science 1993;260:1640–1643.

    Article  PubMed  CAS  Google Scholar 

  25. Gertz BJ, Barrett JS, Eisenhandler R, et al. Growth hormone response in man to L­692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 1993;77:1393–1397.

    Article  PubMed  CAS  Google Scholar 

  26. Hickey G, Jacks T, Judith F, et al. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles. Endocrinology 1994;134:695–701.

    Article  PubMed  CAS  Google Scholar 

  27. Chapman IM, Bach MA, Van Cauter E, et al. Stimulation of the growth hormone (GH)­insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 1996;81:4249–4257.

    Article  PubMed  CAS  Google Scholar 

  28. Blake AD, Smith RG. Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-D-Phe-Lys-NH2 stimulate GH release through different receptor sites. J Endocrinol 1991;129:11–19.

    Google Scholar 

  29. Cheng K, Chan WW, Barreto A, Convey EM, Smith RG. The synergistic effects of His­D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3’,5’-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989;124:2791–2798.

    Article  PubMed  CAS  Google Scholar 

  30. Clark RG, Carlsson LMS, Trojnar J, Robinson ICAF. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinology 1989:1;249–255.

    Article  CAS  Google Scholar 

  31. Chang CH, Rickes EL, Marsilio F, et al. Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine. Endocrinology 1995;136:1065–1071.

    Article  PubMed  CAS  Google Scholar 

  32. Wu D, Chen C, Katoh K, Zhang J, Clarke J. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol 1994:140;9–13.

    Article  Google Scholar 

  33. Jansson J-O, Downs TR, Beamer WG, Frohman LA. The dwarf “little” (lit/lit) mouse is resistant to growth hormone (GH)-releasing peptide (GH-RP-6) as well as to GH-releasing hormone (GRH). 68th Ann Meeting Endocr Soc 1986 abs 397.

    Google Scholar 

  34. Renner U, Brockmeier S, Strasburger CJ, et al. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. J Clin Endocrinol Metab 1994:78;1090–1096.

    Article  PubMed  CAS  Google Scholar 

  35. Badger TM, Millard WJ, McCormick GF, Bowers CY, Martin JB. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 1984:115;1432–1438.

    Article  PubMed  CAS  Google Scholar 

  36. Akman MS, Girard M, O’Brien LF, Ho AK, Chik CL. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta-Nal-Ala-Trp-D-Phe-Lys­NH2) in rat anterior pituitary cells. Endocrinology 1993:132;1286–1291.

    Article  PubMed  CAS  Google Scholar 

  37. Sartor O, Bowers CY, Chang D. Parallel studies of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rat primary pituitary cell monolayer culture. Endocrinology 1985;116:952–957.

    Article  PubMed  CAS  Google Scholar 

  38. Pong SS, Chaung L-YP, Smith RG. GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) stimulates growth hormone secretion by depolarization in rat pituitary cell cultures. 73th Ann Meeting Endocr Soc 1991 abs 88.

    Google Scholar 

  39. Cheng K, Chan WW, Butler B, Barreto A, Smith RG. Evidence for a role of protein kinase-C in His-D-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitray cells. Endocrinology 1991;129:3337–3342.

    Article  PubMed  CAS  Google Scholar 

  40. Cheng K, Chan WW, Butler B, et al. Stimulation of growth hormone release from rat pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology 1993;6:2729–2731.

    Article  Google Scholar 

  41. Pong SS, Chaung L-YP, Dean D, Nargund RP, Patchett AA, Smith RG. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10:57–61.

    Article  PubMed  CAS  Google Scholar 

  42. Howard AD, Feighner SD, Cully DF, et al. Cloning of a G-protein coupled receptor for the growth hormone releasing peptide (GHRP-6) and non-peptidyl growth hormone secretagogues. Science 1996;273:974–977.

    Article  PubMed  CAS  Google Scholar 

  43. Sethumadhavan K, Veeraragavan K, Bowers CY. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem Biophys Res Commun 1991;178:31–37.

    Article  PubMed  CAS  Google Scholar 

  44. Codd EE, Shu AYL, Walker RF. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 1989;28:1139­-1144.

    Article  Google Scholar 

  45. Veeraragavan K, Sethumadhavan K, Bowers CY. Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci 1992;50:1149–1155.

    Article  PubMed  CAS  Google Scholar 

  46. McKee KK, Palyha OC, Feighner SD, et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogues receptors. Mol Endocrinol 1997;11:415-­423.

    Article  PubMed  CAS  Google Scholar 

  47. Bodart V, McNicoll N, Carriere P, et al. Identification and characterization of a new GHRP receptor in the heart. Program of the 80th Meeting of The Endocrine Society, New Orleans LO,1998:302.

    Google Scholar 

  48. Ong H, McNicoll N, Escher E, et al. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labelling. Endocrinology 1998;139:432­-435.

    Article  PubMed  CAS  Google Scholar 

  49. Berti F, Rossoni G, Magni G, et al. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin. J Cardiovasc Pharmacol 1988;12:438–444.

    Article  PubMed  CAS  Google Scholar 

  50. De Gennaro Colonna V, Rossoni G, Bonacci D, et al. Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency. Eur J Pharmacol 1996;314:333–338.

    Article  PubMed  Google Scholar 

  51. De Gennaro Colonna V, Rossoni G, Bernareggi M, Muller EE, Bern F. Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: protection by hexarelin. Eur J Pharmacol 1997;334:201–207.

    Article  PubMed  Google Scholar 

  52. Lakatta EG, Yin FC. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927–941.

    PubMed  CAS  Google Scholar 

  53. Ji LL, Dillon D, Wu E. Myocardial aging: antioxidant enzyme systems and related biochemical properties. Am J Physiol 1991;261:R386–392.

    PubMed  CAS  Google Scholar 

  54. Mudumbi RV, Olson RD, Hubler BE, Montamat SC, Vestal RE. Age-related effects in rabbit heart of N6-R-phenylisopropyladenosine, an adenosine Al receptor agonist. Gerontology 1995;50A:B351–357.

    CAS  Google Scholar 

  55. Sonntag WE, Steger RW, Forman LJ, Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 1980;107:1875–1879.

    Article  PubMed  CAS  Google Scholar 

  56. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population. J Clin Invest 1981;67:1361–1369.

    Article  PubMed  CAS  Google Scholar 

  57. Torsello A, Luoni M, Grilli R, et al. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function. Neuroendocrinology 1997;65:91–97.

    Article  PubMed  CAS  Google Scholar 

  58. Deghenghi R. Structural requirements of growth hormone secretagogues. In: Bercu BB and Walker RF (eds) Growth hormone secretagogues in clinical practice. Marcel Dekker Inc, New York, 1998:27–35.

    Google Scholar 

  59. Luoni M, Grilli R, Guidi M, et al. Effects of acute and long-term administration of growth hormone-releasing peptides on GH secretion and feeding behaviour in young-adult and aged rats. Program of the 79th Meeting of The Endocrine Society, Minneapolis MI, 1997:152.

    Google Scholar 

  60. Graziani A, Fubini A, Filigheddu N, et al. Hexarelin, a peptidyl GH secretagogue, is a novel survival factor for cardiomyocytes. J Endocrinol Invest 1999;22(suppl. to n. 4):16.

    Google Scholar 

  61. Valetto MR, Podio V, Broglio F, et al. Hexarelin, a peptidyl GH-secretagogue, increases the left ventricular ejection fraction but not GH secretion in adult patients with severe GH deficiency. Comparison with the effect in normal subjects. J Endocrinol Invest 1999;22(suppl. ton. 4):57.

    Google Scholar 

  62. Meissner A, Morgan JP. Contractile dysfunction and abnormal Cat-1- modulation during postischemic reperfusion in rat heart. Am J Physiol 1995;268:H100–111.

    PubMed  CAS  Google Scholar 

  63. Tsukube T, McCully JD, Federman M, Krukenkamp IB, Levitsky S. Developmental differences in cytosolic calcium accumulation associated with surgically induced global ischemia: optimization of cardioplegic protection and mechanism of action. J Thorac Cardiovasc Surg 1996;112:175–184.

    Article  PubMed  CAS  Google Scholar 

  64. Cavero I, Boudot JP, Feuvray D. Diltiazem protects the isolated rabbit heart from the mechanical and ultrastructural damage produced by transient hypoxia, low-flow ischemia and exposure to Cat+-free medium. J Pharmacol Exp Ther 1983;226:258–268.

    PubMed  CAS  Google Scholar 

  65. Nayler WG, Elz JS. Reperfusion injury: laboratory artifacts or clinical dilemma? Circulation 1986;74:215–221.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Milano-Bicocca, Italy

    Vittorio Locatelli, Antonio Torsello, Micaela Bernareggi & Ferruccio Berti

  2. Dept of Pharmacology, France

    Giuseppe Rossoni, Elena Bresciani, Vito De Gennaro Colonna & Eugenio E. Müller

  3. lnst. of Pharmacological Sciences, University of Milano, Italy

    Giuseppe Rossoni

  4. Europeptides, Argenteuil, France

    Romano Deghenghi

Authors
  1. Vittorio Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Rossoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Torsello
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Micaela Bernareggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elena Bresciani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vito De Gennaro Colonna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Romano Deghenghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eugenio E. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ferruccio Berti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Endocrine Section Department of Internal Medicine, University of Brescia, Italy

    Andrea Giustina M.D.  & Filippo Manelli M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Locatelli, V. et al. (2001). Growth Hormone-Releasing Peptides And The Heart. In: Giustina, A., Manelli, F. (eds) Growth Hormone And The Heart. Endocrine Updates, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1579-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1579-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5624-0

  • Online ISBN: 978-1-4615-1579-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation